Anne Marie Finley, Biotech Policy Group Founder and Principal, was named a “Top 50 Thought-Leaders in Orphan Drugs and Rare Diseases” by the World Orphan Drug Congress in 2014.

She is “an expert with access to different national regulators, Anne Marie has a unique holistic perspective on the challenges surrounding orphan drug development across multiple markets.”

Read more about her inclusion in this prestigious publication here